A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma
暂无分享,去创建一个
N. Burwick | P. Becker | W. Bensinger | T. Kim | D. Moore | D. Green | T. Dennie | K. Kojouri | T. Gooley | Y. Inoue | E. Nelli